Statistical analysis as a cause of white-coat hypertension

Journal of Hypertension

Volumn 35, Issue 4, 2017, Pages 707-709

  Myers, Martin G ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT;

AMBULATORY MONITORING; BLOOD PRESSURE MONITORING; CARDIOVASCULAR RISK; CLINICAL PRACTICE; EVIDENCE BASED PRACTICE; HOME MONITORING; HUMAN; LIFESTYLE MODIFICATION; MASKED HYPERTENSION; META ANALYSIS (TOPIC); OUTCOME ASSESSMENT; PRACTICE GUIDELINE; PREHYPERTENSION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK FACTOR; STATISTICAL ANALYSIS; SYSTOLIC HYPERTENSION; WHITE COAT HYPERTENSION;

EID: 85009371848     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000001232     Document Type: Review

References (17)

1. National Institute for Health and Clinical Excellence (NICE). Hypertension. The clinical management of primary hypertension in adults. Clinical Guideline 2011;127; https://www.nice.org.uk/guidance/CG127. Accessed September 30, 2016.
2. Piper MA, Evans CV, Burda BU, Margolis KL, O'Connor E, Whitlock EP. Diagnostic and predictive accuracy of blood pressure screening methods with consideration of rescreening intervals: A systematic review for the U.S. Preventive Services Task Force. Ann Intern Med 2015; 162:192-204.
3. Daskalopoulou SS, Rabi DM, Zarnke KB, Dasgupta K, Nerenberg K, Cloutier L, et al. The 2015 Canadian Hypertension Education Program rcommendations for blood pressure measurement, diagnosis, assessment of risk, prevention and treatment of hypertension. Can J Cardiol 2015; 31:549-568.
4. Weber ME, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson KG, et al. Clinical practice guidelines for the management of hypertension in the community: A statement of the American Society of Hypertension and the International Society of Hypertension. J Hypertens 2014; 32:3-15.
5. Mancia G, Fagard R, Krzysztof N, Redon J, Zanchetti A, Bohm M, et al., Task Force Members. 2013 ESH/ESC guidelines for the management of arterial hypertension. J Hypertens 2013; 31:1281-1357.
6. Pickering WG. High blood pressure, Second edition. London, UK: J&A Churchill Ltd; 1968.
7. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R, Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: A meta-Analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.
8. O'Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens 2013; 31:1731-1768.
9. Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al., ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: A summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008; 26:1505-1526.
10. Cuspidi C, Rescaldani M, Tadic M, Sala C, Grassi G, Mancia G. White coat hypertension, as defined by ambulatory blood pressure monitoring and subclinical cardiac organ damage: A meta-Analysis. J Hypertens 2015; 33:24-32.
11. Briasoulis A, Androulakis E, Palla M, Papageorgiou N, Tousoulis D. White-coat hypertension and cardiovascular events: A meta-Analysis. J Hypertens 2016; 34:593-599.
12. Hansen TW, Kikuya M, Thijs L, Bjorklund-Bodegard K, Kuznetsova T, Ohkubo T, et al., IDACO Investigators. Prognostic superiority of daytime ambulatory conventional blood pressure in four populations: A meta-Analysis of 7030 individuals. J Hypertens 2007; 25:1554-1564.
13. Franklin SS, Thijs L, Hansen TW, Li Y, Boggia J, Kikuya M, et al., International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes Investigators. Significance of white coat hypertension in older persons with isolated systolic hypertension. A meta-Analysis using the International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes investigators. Hypertension 2012; 59:564-571.
14. Asayama K, Thijs L, Li Y, Gu YM, Hara A, Liu YP, et al., International Database on Ambulatory Blood Pressure in Relation to Cardiovascular Outcomes (IDACO) Investigators. Setting thresholds to varying blood pressure monitoring intervals differentially affects risk estimates associated with white coat and masked hypertension in the population. Hypertension 2014; 64:935-942.
15. Stergiou GS, Asayama K, Thijs L, Kolias A, Niiranen TJ, Hozawa A, et al., International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators. Prognosis of white coat and masked hypertension: International database of home blood pressure in relation to cardiovascular outcome. Hypertension 2014; 63:675-682.
16. Mancia G. Clinical significance of white-coat hypertension. J Hypertens 2016; 34:623-626.
17. Myers MG, Stergiou GS. White coat phenomenon. Removing the stigma of hypertension. Hypertension 2016; 67:1111-1113.